Clinical Trial Update: Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial [Phase 2]

View source ↗

Summary

This Clinical Trial Update describes a Phase 2 study evaluating adjunct omega-3 long-chain polyunsaturated fatty acids in pulmonary tuberculosis, focusing on ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Omega-3 long-chain polyunsaturated fatty acids (adjunct) (omega-3 long-chain polyunsaturated fatty acids)

Snippet

Sponsor: North-West University, South Africa | Conditions: Tuberculosis, Inflammation Biomarkers | Phase 2 | Status: NOT_YET_RECRUITING